In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. January 02, 2019

    2nd Bellwether Track Set In Opioid MDL

    The Ohio federal judge overseeing the opioid multidistrict litigation has issued an order creating a second track of bellwether cases, saying the first track of cases represents a large but incomplete portion of the issues relevant to the litigation.

  2. January 01, 2019

    Health Care Cases To Watch In 2019

    The health care industry in 2019 will watch with bated breath as a guillotine hangs over the Affordable Care Act, historic litigation involving the opioid crisis heads to trial and the murky meaning of a landmark False Claims Act decision becomes clearer. Here, Law360 gets attorneys up to speed on must-watch cases in the year ahead.

  3. January 01, 2019

    Native American Cases To Watch In 2019

    In the new year, Native American law practitioners will be keeping an eye on upcoming U.S. Supreme Court decisions regarding Washington's ability to tax the Yakama Nation; treaty hunting rights in Wyoming; and the balance of tribal, federal and state criminal jurisdiction in Oklahoma. Here, Law360 takes a look at the cases attorneys who practice Native American law will be watching in the coming year.

  4. January 01, 2019

    Life Sciences Cases To Watch In 2019

    The life sciences industry will be keeping an eye on courtrooms around the country in 2019, watching to see how the U.S. Supreme Court decides a legal battle over patent protection for drugs and monitoring the fallout from federal prosecutors' decision to spike a False Claims Act case. Here are seven cases life sciences attorneys say they'll be following in the coming year.

  5. January 01, 2019

    Product Liability Cases To Watch In 2019

    Product liability attorneys are closely watching two appeals at the U.S. Supreme Court — one over Merck's osteoporosis drug Fosamax and another involving asbestos and maritime law — as well as the enormous multidistrict litigation over the opioid crisis and suits alleging that Monsanto’s weedkiller Roundup causes cancer. Here, Law360 summarizes the top cases product liability attorneys will be following in 2019.

  6. December 19, 2018

    Ohio Opioid MDL Bellwether Survives Drug Co. Attacks

    An Ohio federal judge on Wednesday cleared a bellwether suit in the multidistrict litigation over the opioid crisis to move forward, largely signing off on a magistrate judge's recommendation.

  7. December 18, 2018

    Where 5 Top MDLs Stand At The End Of 2018

    The past year was a lively one on the multidistrict litigation docket as major MDLs over the opiate crisis and the Equifax data breach got up and running, while cases concerning a Monsanto weedkiller and a common hospital technology revved for early bellwether trials.

  8. December 06, 2018

    'Opioid Babies' Denied MDL Separate From Ohio Gov't Suits

    The U.S. Judicial Panel on Multidistrict Litigation on Thursday denied a request from plaintiffs representing "opioid babies" — infants of mothers who were addicted to prescription drugs — to separate their suits into a distinct multidistrict litigation, ruling that their unique damages don't outweigh the inconvenience caused by such a separation.

  9. December 04, 2018

    Tribes Can't Seek Info On Fed Contracts, IHS In Opioid MDL

    An Ohio federal judge on Tuesday refused nearly two dozen Indian tribes' request to conduct further discovery of federal contracts so they can avoid being treated disparately from government entities in an ongoing opioid multidistrict litigation, ruling that the court has already identified cases that discuss the tribes' legal issues.

  10. November 29, 2018

    JPML Wary Of Special Litigation For 'Opioid Babies'

    The Judicial Panel on Multidistrict Litigation appeared disinclined Thursday to create a new MDL for "opioid babies" whose mothers used prescription narcotics, sharply questioning whether such a move would actually expedite the infants' suits.